The present invention discloses a novel pharmaceutical formulation exhibiting antiviral activity against virus comprising of HBV, HIV, HSV1, HSV2, H1N1 Influenza and combinations thereof. The formulation of the present invention comprises of therapeutically effective amount of citronellyl propionate, therapeutically effective amount of megastimatrienone and atleast one suitable pharmaceutically acceptable excipient, additives and carriers.